Bionovo Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials

Questions: Discounts, Updates etc.

Price: $495.00

Publication Date: 11-Jun-08

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

Bionovo is a biopharmaceutical company developing women's health and oncology drugs isolated from botanical sources, as well as new chemical entities (NCEs). The company's clinical program selects promising plant extracts used in traditional Chinese medicine which is then screened against well-understood therapeutic targets using rigorous biological assays.


Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


    • Report Highlights
    Bionovo's most advanced program, MF101, completed Phase II trials for the treatment of menopausal symptoms and is expected to enter Phase III trials in 2008. The company's second product, BZL101, is currently in Phase II trials for the treatment of advanced breast cancer, with results expected in 2009.

    Bionovo derives its entire revenues from the licensing agreement with United Biotech related to the development and commercialization of MF101 and BZL101 in Taiwan. The company's total revenues increased at a CAGR of 64% during 2002-2006, from $0.002 million to $0.015 million.

    The company's sole contributor to sales growth out to 2010 will be the revenues from licenses, collaboration and other. These revenues are expected to increase from $0.02 million in 2006 to $3 million in 2010, representing an absolute growth of +$3 million for the period of analysis.


    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization

    • Table of Contents

    Other users found this report page using the following search terms: bionovo swot analysis structure bzl101 inc baxter health mm chemical

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.


    Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.